Hanmi Pharm. Co., Ltd. (KRX:128940)

Hanmi Pharm. Revenue

Hanmi Pharm. had revenue of 392.93B KRW in the quarter ending March 31, 2026, with 0.51% growth. This brings the company's revenue in the last twelve months to 1.55T, up 4.50% year-over-year. In the year 2025, Hanmi Pharm. had annual revenue of 1.55T with 3.48% growth.

• Revenue (ttm): 1.55T
• Revenue Growth: +4.50%
• P/S Ratio: 3.37
• Revenue / Employee: 645.63M
• Employees: 2,400
• Market Cap: 5.22T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.55T	52.03B	3.48%
Dec 31, 2024	1.50T	4.61B	0.31%
Dec 31, 2023	1.49T	159.34B	11.97%
Dec 31, 2022	1.33T	128.36B	10.67%
Dec 31, 2021	1.20T	127.33B	11.84%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error